LPL Deficiency
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Alipogene Tiparvovec for the Treatment of LPLD Patients (NCT02904772) | UniQure Biopharma B.V. | 2016-10-01 |
Track LPL Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.